Who Owns Filana Therapeutics Stock?
NASDAQ: FLNAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 26.81%
- Held by insiders
- 2.05%
- Institutional holders
- 109
- Institutions 26.8%
- Insiders 2.0%
- Public and other 71.1%
Who owns Filana Therapeutics stock?
Institutional investors own about 26.8% of Filana Therapeutics's shares, spread across 109 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 2.05% of FLNA.
The largest institutional holders are Vanguard Capital Management LLC (4.09%), Two Sigma Investments, LP (3.54%) and Marshall Wace LLP (3.31%). Together, the top 10 institutions control 20.0% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their FLNA positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of FLNA
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Vanguard Capital Management LLC | 1.97M | 4.09% | +2.3% |
| Two Sigma Investments, LP | 1.71M | 3.54% | -13.9% |
| Marshall Wace LLP | 1.60M | 3.31% | -20.6% |
| Blackrock Inc. | 1.45M | 3.01% | +2.8% |
| Goldman Sachs Group Inc | 668.79K | 1.38% | +1518.4% |
| Geode Capital Management, LLC | 615.51K | 1.27% | +3.2% |
| Shaw D.E. & Co., Inc. | 485.02K | 1.00% | -13.3% |
| GMT Capital Corp | 450.10K | 0.93% | 0.0% |
| Renaissance Technologies, LLC | 389.60K | 0.81% | +19.2% |
| Squarepoint Ops LLC | 318.38K | 0.66% | +100.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of FLNA
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.37M | 2.83% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 563.88K | 1.17% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 254.14K | 0.53% |
| iShares Trust-iShares Micro-Cap ETF | 147.61K | 0.31% |
| VANGUARD WORLD FUND-Vanguard Health Care Index Fund | 132.12K | 0.27% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 81.46K | 0.17% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 72.47K | 0.15% |
| GOLDMAN SACHS TRUST-Goldman Sachs Absolute Return Tracker Fund | 42.60K | 0.09% |
| TR PRICE-Price (T.Rowe) U.S. Equities Trust | 40.86K | 0.08% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 39.95K | 0.08% |
Frequently asked questions
Who is the largest shareholder of Filana Therapeutics?
Vanguard Capital Management LLC is the largest institutional shareholder of FLNA, owning 4.09% of shares outstanding (1.97M shares) as of its latest 13F filing.
What percentage of Filana Therapeutics is owned by institutions?
Institutions own about 26.8% of FLNA shares and 27.4% of the public float.
How much of Filana Therapeutics do insiders own?
Insiders, such as officers and directors, own about 2.05% of FLNA shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.